Infliximab biosimilar-induced lupus nephritis: A case report
- 30 October 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 8 (1) , 74-76
Abstract
We present a case of microhematuria, proteinuria and hypocomplementemia which developed in a 55-year-old female who was being treated with an infliximab biosimilar for rheumatoid arthritis. Renal biopsy showed lupus nephritis (ISN/RPS classification class IV + V). Treatment with the infliximab biosimilar was discontinued, and treatment with prednisolone, hydroxychloroquine and abatacept was started, resulting in clinical remission of lupus nephritis and RA. Although tumour necrosis factor-α α inhibitors are known to induce production of autoantibodies, symptoms are usually limited to skin involvement or arthritis, and renal complications are rare. Physicians should be aware of the risk of lupus nephritis and carefully monitor patients for the development of renal involvement during treatment with tumour necrosis factor-α inhibitors.Keywords
This publication has 10 references indexed in Scilit:
- Adalimumab-Induced Lupus Nephritis: Case Report and Review of the LiteratureEuropean Journal of Rheumatology, 2022
- Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of LiteratureClinics and Practice, 2021
- Anti‐TNF‐induced lupus in patients with inflammatory bowel diseaseJGH Open, 2019
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusArthritis & Rheumatology, 2019
- Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literatureClinical Rheumatology, 2017
- Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trialLupus Science & Medicine, 2017
- Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RARMD Open, 2017
- Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohortAutoimmunity Reviews, 2014
- Autoimmune Diseases Induced by TNF-Targeted TherapiesMedicine, 2007
- Drug‐Induced LupusAnnals of the New York Academy of Sciences, 2007